Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Normal cardiac and respiratory functions should be maintained during pediatric cardiac catheterization. Propofol has become a popular choice for sedation in children, however, it depresses cardiac and respiratory functions. Some investigators reported that ketamine attenuates its depressant effect, but it remains unclear whether ketamine reduces cardiac and respiratory depression caused by propofol in pediatric cardiac catheterization.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| control | Sham Comparator | propofol and saline are administered |
|
| Ket10 | Experimental | ketamine is co-administered with propofol |
|
| Ket20 | Experimental | ketamine is co-administered with porpofol |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| control | Drug | propofol 8mg/kg/h saline 0.24 ml/kg/h |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| difference of end tidal partial pressure of carbon dioxide between the groups | 30 and 60 min after anesthetic induction | |
| difference of partial pressure of arterial carbon dioxide between the groups | 60 min after anesthetic induction on average | |
| heart rate change from baseline value | 30 and 60 min after anesthetic induction | |
| non-invasive blood pressure change from baseline value | 30 and 60 min after anesthetic induction |
| Measure | Description | Time Frame |
|---|---|---|
| movement at topical anesthetic injection |
|
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Kazuhiko Okuyama, MD | Ibaraki Children's Hospital | Study Chair |
| Yuki Takeda, MD | Ibaraki Children's Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ibaraki Children's Hospital | Mito | Ibaraki | 311-4145 | Japan |
Not provided
| ID | Term |
|---|---|
| D006330 | Heart Defects, Congenital |
| ID | Term |
|---|---|
| D018376 | Cardiovascular Abnormalities |
| D002318 | Cardiovascular Diseases |
| D006331 | Heart Diseases |
| D000013 | Congenital Abnormalities |
Not provided
Not provided
| ID | Term |
|---|---|
| D012965 | Sodium Chloride |
| D015742 | Propofol |
| ID | Term |
|---|---|
| D002712 | Chlorides |
| D006851 | Hydrochloric Acid |
| D017606 | Chlorine Compounds |
| D007287 | Inorganic Chemicals |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Ket10 | Drug | propofol 6.4 mg/kg/h ketamine 10 microg/kg/min |
|
|
| Ket20 | Drug | propofol 4.8 mg/kg/h ketamine 20 microg/kg/min |
|
|
| 20 min after anesthetic induction on average |
| the number of times that secreted saliva is aspirated by an attending anesthesiologist | From anesthetic induction to termination of anethetics administration, which is not over 2 hours from anesthetic induction |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D017670 |
| Sodium Compounds |
| D010636 | Phenols |
| D001555 | Benzene Derivatives |
| D006841 | Hydrocarbons, Aromatic |
| D006844 | Hydrocarbons, Cyclic |
| D006838 | Hydrocarbons |
| D009930 | Organic Chemicals |